Home Medicine Impact of total automation consolidating first-line laboratory tests on diagnostic blood loss
Article
Licensed
Unlicensed Requires Authentication

Impact of total automation consolidating first-line laboratory tests on diagnostic blood loss

  • Sara Pasqualetti EMAIL logo , Elena Aloisio , Sarah Birindelli , Alberto Dolci and Mauro Panteghini
Published/Copyright: May 30, 2019

Abstract

Background

Blood loss for laboratory testing may contribute to hospital-acquired anemia. When implementing the core laboratory (core-lab) section, we consolidated first-line tests decreasing the number of tubes previously dispatched to different sites. Here, hypothesized benefits of the amount of blood volume drawn were explored.

Methods

We retrieved, using a laboratory information system (LIS), the number of tubes received by laboratories interested in the change from all clinical wards in a year-based period, i.e. 2013 for pre-core-lab and 2015 for core-lab system, respectively. Data were expressed as the overall number of tubes sent to laboratories, the corresponding blood volume, and the number of laboratory tests performed, normalized for the number of inpatients.

Results

After consolidation, the average number of blood tubes per inpatient significantly decreased (12.6 vs. 10.7, p < 0.001). However, intensive care units (ICUs) did not reduce the number of tubes per patient, according to the needs of daily monitoring of their clinical status. The average blood volume sent to laboratories did not vary significantly because serum tubes for core-lab required higher volumes for testing up to 55 analytes in the same transaction. Finally, the number of requested tests per patient during the new osystem slightly decreased (−2.6%).

Conclusions

Total laboratory automation does not automatically mean reducing iatrogenic blood loss. The new system affected the procedure of blood drawing in clinical wards by significantly reducing the number of handled tubes, producing a benefit in terms of costs, labor and time consumption. Except in ICUs, this also slightly promoted some blood saving. ICUs which engage in phlebotomizing patients daily, did not take advantage from the test consolidation.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  6. Ethical approval: Not applicable.

References

1. McEvoy M, Shander A. Anemia, bleeding, and blood transfusion in the intensive care unit: causes, risks, costs, and new strategies. Am J Crit Care 2013;22:eS1–13.10.4037/ajcc2013729Search in Google Scholar PubMed

2. Walsh TS, Saleh EE. Anaemia during critical illness. Br J Anaesth 2006;97:278–91.10.1093/bja/ael189Search in Google Scholar PubMed

3. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT study: anemia and blood transfusion in the critically ill – current clinical practice in the United States. Crit Care Med 2004;32:39–52.10.1097/01.CCM.0000104112.34142.79Search in Google Scholar PubMed

4. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009;113:3406–17.10.1182/blood-2008-10-167643Search in Google Scholar PubMed

5. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50:753–65.10.1111/j.1537-2995.2009.02518.xSearch in Google Scholar PubMed

6. Languasco A, Cazap N, Marciano S, Huber M, Novillo A, Poletta F, et al. Hemoglobin concentration variations over time in general medical inpatients. J Hosp Med 2010;5:283–8.10.1002/jhm.650Search in Google Scholar PubMed

7. Koch CG, Li L, Sun Z, Hixson ED, Tang A, Phillips SC, et al. Hospital-acquired anemia: prevalence, outcomes, and healthcare implications. J Hosp Med 2013;8:506–12.10.1002/jhm.2061Search in Google Scholar PubMed

8. Aloisio E, Pasqualetti S, Dolci A, Panteghini M. Hospital-acquired anemia: the role of diagnostic blood loss. Biochim Clin 2017;41:208–15.Search in Google Scholar

9. Hayden SJ, Albert TJ, Watkins TR, Swenson ER. Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med 2012;185:1049–57.10.1164/rccm.201110-1915CISearch in Google Scholar PubMed PubMed Central

10. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU: is there a reason? Chest 1995;108:767–71.10.1378/chest.108.3.767Search in Google Scholar PubMed

11. Chant C, Wilson G, Friedrich JO. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care 2006;10:R140.10.1186/cc5054Search in Google Scholar PubMed PubMed Central

12. Thomas J, Jensen L, Nahirniak S, Gibney RT. Anemia and blood transfusion practices in the critically ill: a prospective cohort review. Heart Lung 2010;39:217–25.10.1016/j.hrtlng.2009.07.002Search in Google Scholar PubMed

13. Salisbury AC, Reid KJ, Alexander KP, Masoudi FA, Lai SM, Chan PS, et al. Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction. Arch Intern Med 2011;171:1646–53.10.1001/archinternmed.2011.361Search in Google Scholar PubMed

14. Salisbury AC, Alexander KP, Reid KJ, Masoudi FA, Rathore SS, Wang TY, et al. Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2010;3:337–46.10.1161/CIRCOUTCOMES.110.957050Search in Google Scholar PubMed PubMed Central

15. Thavendiranathan P, Bagai A, Ebidia A, Detsky AS, Choudhry NK. Do blood tests cause anemia in hospitalized patients? The effect of diagnostic phlebotomy on hemoglobin and hematocrit levels. J Gen Intern Med 2005;20:520–4.10.1111/j.1525-1497.2005.0094.xSearch in Google Scholar PubMed PubMed Central

16. https://www.blood.gov.au/pbm-guidelines. Accessed January 2019.Search in Google Scholar

17. Eaton KP, Levy K, Soong C, Pahwa AK, Petrilli C, Ziemba JB, et al. Evidence-based guidelines to eliminate repetitive laboratory testing. J Am Med Assoc Intern Med 2017;177:1833–9.10.1001/jamainternmed.2017.5152Search in Google Scholar PubMed

18. Ferraro S, Braga F, Panteghini M. Laboratory medicine in the new healthcare environment. Clin Chem Lab Med 2016;54:523–33.10.1515/cclm-2015-0803Search in Google Scholar PubMed

19. Ferraro S, Panteghini M. The role of laboratory in ensuring appropriate test requests. Clin Biochem 2017;50:555–61.10.1016/j.clinbiochem.2017.03.002Search in Google Scholar PubMed

20. Rubinstein M, Hirsch R, Bandyopadhyay K, Madison B, Taylor T, Ranne A, et al. Effectiveness of practices to support appropriate laboratory test utilization: a laboratory medicine best practices systematic review and meta-analysis. Am J Clin Pathol 2018;149:197–221.10.1093/ajcp/aqx147Search in Google Scholar PubMed PubMed Central

21. Fischer DP, Zacharowski KD, Meybohm P. Savoring every drop – vampire or mosquito? Crit Care 2014;18:306.10.1186/cc13884Search in Google Scholar PubMed PubMed Central

22. Stefanini M. Iatrogenic anemia (can it be prevented?). J Thromb Haemost 2014;12:1591.10.1111/jth.12642Search in Google Scholar PubMed

23. Patel K, Brown SM, Dietzen DJ. Listening closely when the volume is turned down challenges to small volume testing. Clinical Laboratory News, May 2016. Available at https://www.aacc.org/publications/cln/articles/2016/may/listening-closely-when-the-volume-is-turned-down. Accessed January 2019.Search in Google Scholar

24. Levi M. Twenty-five million liters of blood into the sewer. J Thromb Haemost 2014;12:1592.10.1111/jth.12656Search in Google Scholar PubMed

25. Dale JC, Ruby SG. Specimen collection volumes for laboratory tests. Arch Pathol Lab Med 2003;127:162–8.10.5858/2003-127-162-SCVFLSearch in Google Scholar PubMed

26. Dolci A, Giavarina D, Pasqualetti S, Szőke D, Panteghini M. Total laboratory automation: Do stat tests still matter? Clin Biochem 2017;50:605–11.10.1016/j.clinbiochem.2017.04.002Search in Google Scholar PubMed

27. Ialongo C, Porzio O, Giambini I, Bernardini S. Total automation for the core laboratory: improving the turnaround time helps to reduce the volume of ordered STAT tests. J Lab Autom 2016;21:451–8.10.1177/2211068215581488Search in Google Scholar PubMed

28. Lippi G, Panteghini M, Bernardini S, Bonfanti L, Carraro P, Casagranda I, et al. Laboratory testing in the emergency department: an Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) and Academy of Emergency Medicine and Care (AcEMC) consensus report. Clin Chem Lab Med 2018;56:1655–9.10.1515/cclm-2017-0077Search in Google Scholar PubMed

29. Pasqualetti S, Birindelli S, Aloisio E, Dolci A, Panteghini M. Clinical governance remains a priority in total laboratory automation era. JALM. 2019. DOI: 10.1373/jalm.2018.028035 [ahead of print].10.1373/jalm.2018.028035Search in Google Scholar PubMed

30. Ng VL. Utilization management in the core laboratory. Clin Chim Acta 2014;427:154–7.10.1016/j.cca.2013.09.038Search in Google Scholar PubMed

31. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. J Am Med Assoc 2002;288:1499–507.10.1001/jama.288.12.1499Search in Google Scholar PubMed

32. Jones RL, Sayles HR, Fey PD, Rupp ME. Effect of clinical variables on the volume of blood collected for blood cultures in an adult patient population. Infect Control Hosp Epidemiol 2017;38:1493–7.10.1017/ice.2017.230Search in Google Scholar PubMed

Received: 2019-02-04
Accepted: 2019-05-01
Published Online: 2019-05-30
Published in Print: 2019-10-25

©2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Identification and management of spurious hemolysis: controversies, concerns and criticisms
  4. Reviews
  5. CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype
  6. Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?
  7. Opinion Paper
  8. Collection, transport and storage procedures for blood culture specimens in adult patients: recommendations from a board of Italian experts
  9. General Clinical Chemistry and Laboratory Medicine
  10. Using the hemoglobin-binding Staphylococcus aureus protein IsdH to enable plasma analysis of hemolyzed blood samples
  11. Handling of hemolyzed serum samples in clinical chemistry laboratories: the Nordic hemolysis project
  12. Clinical biomarker innovation: when is it worthwhile?
  13. Impact of total automation consolidating first-line laboratory tests on diagnostic blood loss
  14. Diagnostic and prognostic value of the D-dimer test in emergency department patients: secondary analysis of an observational study
  15. Screening of chemical libraries in pursuit of kallikrein-5 specific inhibitors for the treatment of inflammatory dermatoses
  16. Comparison of five automated urine sediment analyzers with manual microscopy for accurate identification of urine sediment
  17. Establishment of an international autoantibody reference standard for human anti-DFS70 antibodies: proof-of-concept study for a novel Megapool strategy by pooling individual specific sera
  18. Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience
  19. Performance evaluation of an Indoxyl Sulfate Assay Kit “NIPRO”
  20. Variable and inaccurate serum IgG4 levels resulting from lack of standardization in IgG subclass assay calibration
  21. Hematology and Coagulation
  22. Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma
  23. Reference Values and Biological Variations
  24. Reference intervals for serum total vitamin B12 and holotranscobalamin concentrations and their change points with methylmalonic acid concentration to assess vitamin B12 status during early and mid-pregnancy
  25. Cardiovascular Diseases
  26. Serum concentrations of free fatty acids are associated with 3-month mortality in acute heart failure patients
  27. Letters to the Editor
  28. Management of potassium results in haemolysed plasma samples at the emergency department laboratory
  29. Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis
  30. Total laboratory automation has the potential to be the field of application of artificial intelligence: the cyber-physical system and “Automation 4.0”
  31. 99th percentile upper reference limit of AccuTnI+3 in a Korean reference population: a multicenter study using fresh serum
  32. Roche Troponin T hs-STAT meets all expert opinion analytical laboratory practice recommendations for the use of the differential diagnosis of acute coronary syndrome
  33. A comparison of biotin interference in routine immunoassays on the Roche Cobas 8000, Beckman Coulter DXi and Siemens Advia Centaur XPT immunoassay platforms
  34. The importance of the methodology and sample matrix when interpreting chromogranin A results
  35. The sudden death of the combined first trimester aneuploidy screening, a single centre experience in Belgium
  36. Reply to Luksic et al. Clin Chem Lab Med 2018;56(4):574–581
Downloaded on 4.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2019-0133/html
Scroll to top button